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ABSTRACT
Type 2 diabetes (T2DM) is a multisystemic disease that affects more than 370 million
people worldwide and costs the U.S. Healthcare System over $245 billion per year (Kahn et al.,
2013; Powers et al., 2015). Current diabetes education serves as a beneficial intervention method
in the prevention and limitation of disease complications. Nevertheless, the current education
regimen does not adequately convey the physiological reasoning behind those recommendations.
Creating an educational tool that provides patients with physiological reasoning behind diabetes
and treatment methods was needed to improve diabetes understanding. Neighborhood
HealthSource expressed a need for easily understandable and accessible pathophysiology-based
T2DM education materials that patients can utilize during their clinic visits (R. Kirchner,
personal communication, January 12, 2022). An electronic pamphlet to fulfill this need was
created and incorporates patient-friendly information on the disease pathophysiology,
complication pathophysiology, risk factors, and diabetes-related terminology. This project served
to alleviate a gap in patient understanding by providing a resource that emphasized patient
understanding of the pathophysiology behind diabetes diagnoses. Neighborhood HealthSource
found the pamphlet to be beneficial and expressed that there appeared to be a better overall initial
patient understanding regarding their T2DM diagnosis (Appendix B). The project’s basis, design
and implementation was successful.
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Chapter 1: Introduction
Introduction
Type 2 diabetes mellitus (T2DM) affects more than 370 million individuals worldwide
(Kahn et al., 2013). Current literature emphasizes blood glucose control by medication and
lifestyle modifications to limit diabetes complications and poor outcomes. Patients with diabetes
receive education about the importance of medications and lifestyle modifications; however,
there is a lack of patient understanding of the physiology of T2DM. There is a gap in the
literature and resources regarding patient comprehension of pathophysiology, suggesting the
need for these resources to be created. Neighborhood HealthSource (NHS) is a community clinic
that serves a diverse patient population consisting of insured and uninsured patients
(Neighborhood HealthSource, 2022). Neighborhood HealthSource had the need for digitally
available and distributable diabetes related physiologic resources. This project’s aim was to
develop a physiology-based educational pamphlet for NHS patients with T2DM. This section
will provide a background on diabetes and address the project’s problem statement, purpose,
significance and limitations.
Background to the Problem
Diabetes mellitus (DM) is a group of diseases that are categorized by the body’s inability
to regulate blood glucose due to metabolic abnormalities (American Diabetes Association,
2010). Type 2 diabetes (T2DM) accounts for the majority of diabetes diagnoses and occurs as a
result of insulin resistance, which then leads to a decreased ability to secrete insulin (Kahn et al.,
2013). Treatment methods for type 2 diabetes include, but are not limited to, hormonal injectable
insulins, sodium-glucose co-transporter 2 oral tablets, and other drugs mediated by the
gastrointestinal tract (Kahn et al., 2013).
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Patient education serves as a beneficial adjunct to pharmaceutical treatment methods in
disease management and blood glucose regulation. Hemoglobin A1C (HbA1C) is a laboratory
value that reflects the average blood glucose over a three-month period and is utilized to
diagnose and assess diabetes management (Trivedi et al., 2017). Diabetes education programs are
recommended by the American Diabetes Association for newly diagnosed diabetes and as an
annual follow up (American Diabetes Association, 2021). Despite these programs being readily
available, less than seven percent of people who have diabetes with private insurance and five
percent of those with Medicare utilize diabetes self-management education and support (Chrvala
et al., 2015). Additionally, of the individuals partaking in education, only 14.3% are able to
maintain their HbA1C under the target of less than seven percent (Chrvala et al., 2015).
Education and support services incorporate psychosocial components, blood glucose and
medication management, and education on a variety of lifestyle modifications that can aid in
reduction of complications (Powers et al., 2015). Such services proclaim to incorporate an
individual's health literacy, educational level, and current understanding of their diagnoses in
their educational approaches. Nevertheless, with so few patients with diabetes participating in the
provided educational resources, and a small number of those improving HbA1C management,
the question arises if patients truly understand their diagnosis, and how the recommended
treatment methods benefit them (Powers et al., 2015).
Despite the educational resources available to patients with diabetes, there is a gap in
literature regarding educational materials in which patients can learn about the pathophysiology
behind the disease, and the mechanisms of how pharmaceutical and lifestyle modifications
physically improve disease outcomes. PubMed, Cumulative Index to Nursing and Allied Health
Literature (CINAHL), DynaMed, National Center for Biotechnology Information (NCBI), and
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Google Scholar showed a gap in the literature regarding patients’ physiological understanding
behind diabetes, treatment methods, and the use of patient education pertaining to physiological
processes. Nevertheless, studies have shown that comprehension of physiological markers
pertaining to disease control and providing additional patient education were correlated with
improved blood glucose management (Ledford et al., 2020; Beard et al., 2010).
Patients’ understanding of their diagnosis often relies on provider-patient interactions,
online searches, and the attendance of recommended education courses. Ledford et al. (2020)
found that 24% of patients wanted additional information following their initial diagnosis.
Studies have shown that patients who receive more information are more involved in their
disease management, leading to higher compliance (Quinn et al., 2011). Analysis of current
literature suggested that educational resources pertaining to patient understanding of the
physiology behind treatment and diagnosis was needed. By providing accessible and
comprehensive physiological resources to patients, improvements in diabetes understanding were
anticipated.
Problem Statement
Diabetes is a multisystemic disease that has become an epidemic (Kahn et al., 2013).
While T2DM is increasing in prevalence, there is still a lack of patient understanding of the
physiological diagnosis and treatment methods’ impact on the body. Current diabetes education
serves as a beneficial intervention method in the prevention and limitation of disease
complications. However, education services are not widely utilized and primarily emphasize
lifestyle and pharmaceutical treatments rather than patients’ physiological understanding
(Chrvala et al., 2015). Creating an educational tool that provides patients with physiological
reasoning behind diabetes and treatment methods was needed to improve diabetes understanding.
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Purpose
The purpose of this project was to provide an informative resource to patients that
outlines the physiology of diabetes and treatment options. This project anticipated improvement
of patient understanding by providing tangible, comprehensible, and accessible information that
can be referenced outside of a clinical setting, thereby improving disease management.
Educational resources that provide patient-friendly physiological explanations may improve
patient understanding and serve as a beneficial adjunct to current educational resources. The goal
of this project was to increase patient understanding to improve disease outcomes.
Significance of the Project
The prevalence of T2DM among Americans is growing, resulting in economic impact on
the healthcare system. In 2017, the American Diabetes Association (2018), otherwise known as
the ADA, noted the economic cost of diabetes in the United States was $327 billion. This cost is
divided into healthcare costs of $237 billion and $90 billion lost due to decreased productivity of
American employees (American Diabetes Association, 2018). Some American employees with
diabetes require time off for management of the disease, some do not work altogether, and others
prematurely pass away, which creates a loss in revenue and further impacts the nation’s economy
(American Diabetes Association, 2018). This estimate demonstrates the monetary drain that
diabetes creates, not only on the United States healthcare system, but on the United States
economy as well.
In 2012, the estimated burden of diabetes in the United States was $245 billion, of which
$176 billion was in direct medical costs and $69 billion was in reduced productivity (Powers et
al., 2015). These costs were even lower in 2007, with the total being $174 billion and the direct
medical costs and productivity being $116 billion and $58 billion, respectively (American
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Diabetes Association, 2008). These figures suggest the diabetic epidemic has been continuously
increasing, with the overall cost in the United States rising by $153 billion in 10 years. From an
economic standpoint, these figures demonstrate the increased importance in the need to treat and
manage diabetes in America. With the prevalence of diabetes rising, more must be done to
control the increased costs associated with the disease. Reducing disease, complications,
hospitalizations, and mortality will not only directly benefit individual patients, but will also
reduce the cost associated with diabetes in the future economic state of the United States.
An important aspect of patient outcomes is how providers educate their patients on
diabetes management, which should include the use of a Diabetes Care and Education Specialist
(DCES). The American Association of Diabetic Educators (AADE) describes DCES’s as a key
component in the interprofessional, clinical team (American Association of Diabetic Educators,
2012). Diabetes Care and Education Specialist’s provide in-depth patient education, nutrition
therapy, monitorization of glycemic control, medication therapy and management, and
professionals’ education (American Association of Diabetic Educators, 2012). Providers’
explanation of diagnosis as well as promotion of patient utilization of DCES’s and educational
resources is important for disease outcome improvements, specifically, to decrease
diabetes-related complications and hospitalizations (Powers et al., 2015). Complications include,
but are not limited to, congestive heart failure, stroke, myocardial infarction, lower extremity
amputation, diabetic ketoacidosis, and hypoglycemia (“Diabetes State,” 2014).
The Centers for Disease Control and Prevention (CDC) reported that 12,635 diabetic
people were hospitalized in Minnesota in 2014 with one of these complications listed as the
reason for admittance (“Diabetes State,” 2014). The prevalence of diabetes in adult Minnesotans
in 2014 was 8.1% of the state’s population, or 340,600 people (“Diagnosed Diabetes,” 2021). Of
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those adults with T2DM in Minnesota, 3.7% were hospitalized with a complication stemming
from their diabetes diagnosis (“Diagnosed Diabetes,” 2021). According to the 2013 data, the
number of deaths of patients with diabetes in Minnesota above the age of 15 was over 1,100
(“Diabetes State,” 2014). In that same year, over 3,500 individuals died from cardiovascular or
end-stage renal disease related to a diabetes complication (“Diabetes State,” 2014). As the
number of individuals diagnosed with T2DM increases, it is expected that these numbers will
also increase. On average, patients with diabetes have 4.1 years lower life expectancy as a result
of their diagnosis (“Diabetes State,” 2014). More individuals die from diabetic complications
than from uncomplicated diabetes. Educational materials are needed to promote patient
understanding, thereby limiting complications, economic costs and premature death associated
with diabetes.
Barriers
While beneficial outcomes regarding the implementation of physiology-based
educational material were anticipated, several potential limitations with the project were
considered. Provider underutilization may serve as a barrier due to time constraints, personal
value of the information, or forgetfulness to provide the educational resources. This may limit
the material’s effectiveness. Additionally, providing a patient with the pamphlet does not ensure
that the patient adequately comprehends the information. A patient’s level of healthcare
understanding, otherwise known as health literacy, may also affect their level of comprehension.
Patients with lower health literacy tend to believe their comprehension of the material is
sufficient (Ferguson et al., 2015). Overall, English literacy is a limiting factor in the ability to
understand written information. Another consideration affecting the project’s intended outcome
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is patients’ intrinsic motivation. For instance, lack of interest, personal beliefs, and personal
value of the information could lead to inadequate understanding.
Definition of Terms
Diabetes Care and Education Specialist (DCES): Providers of in-depth diabetic education,
nutrition therapy, monitorization of glycemic control, medication therapy and management, and
professionals’ education (American Association of Diabetic Educators, 2012).
Health literacy: The capacity to obtain, process, and understand the basic health information and
services that patients need to make appropriate health decisions (Ratzan et al., 2000).
Hemoglobin A1C (HbA1C): A test that measures the average amount of glucose attached to
hemoglobin over the past three months (U.S. National Library of Medicine, 2021).
Insulin: A hormone that is secreted by the beta cells of the pancreatic islets of Langerhans that
maintains normal blood glucose by facilitating cellular glucose uptake through regulating
carbohydrates, lipid and protein metabolism, and cellular division (Wilcox, 2005).
Type 1 Diabetes (T1DM): An autoimmune condition characterized by abnormalities or
degradation of pancreatic beta cells, which results in the inability of the pancreas to regulate
blood glucose levels (Atkinson et al., 2013).
Type 2 Diabetes (T2DM): A condition that occurs due to insulin resistance, characterized by the
inability of beta cells to maintain normal blood glucose levels due to increased insulin secretion
(Kahn et al., 2013).
Conclusion
Diabetes mellitus serves as a burden to the U.S. healthcare system as well as individuals
with the disease. Therefore, providing patients with educational tools to improve understanding
is needed. This project created an additional educational resource that emphasizes the physiology

12

behind a diabetes diagnosis and treatment with the overall aim to improve disease management
and outcomes by increasing patient health literacy. Chapter two analyzes the pathophysiology of
diabetes and treatment methods, current education, health literacy, and the importance of patient
physiologic understanding.
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Chapter 2: Literature Review
Introduction
Diabetes mellitus (DM) is a group of diseases that are categorized by their inability to
regulate blood glucose due to metabolic abnormalities (American Diabetes Association, 2010).
There have been recent advances in treatment methods and provider understanding of the
disease, and educational tools have shown to be effective at improving patient compliance and
disease management. However, current patient education does not provide patients with a
physiological understanding, though it is anticipated to improve compliance and disease
outcomes. This literature review will outline research on the physiology and treatment methods
of diabetes, effectiveness of current patient education, health literacy considerations, and patient
understanding of diabetes pathophysiology as it relates to their diagnosis and disease
management.
Pathophysiology of Diabetes Mellitus
The endocrine cells found in the pancreas are known as islets of Langerhans and produce
insulin, glucagon and other hormones that are released into the bloodstream to help regulate
blood glucose levels (El Sayed & Mukherjee, 2021). Regarding diabetes, islet cells consist of
pancreatic beta cells that release insulin and alpha cells that release glucagon (El Sayed &
Mukherjee, 2021). The elevation of blood glucose leads to insulin secretion by beta cells, which
absorbs excess sugar from the bloodstream and serves as negative inhibition, signaling the liver
to stop releasing glucose (El Sayed & Mukherjee, 2021). A decrease in blood glucose results in
the release of glucagon from the pancreas, which stimulates the release of glucose from the liver
and into the bloodstream (El Sayed & Mukherjee, 2021).
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Diabetes Mellitus is diagnosed by a laboratory blood test known as hemoglobin A1C
(HbA1C), which shows the average blood glucose levels over the past three months (Eyth &
Naik, 2021). A HbA1C of less than 5.7% is considered non-diabetic, 5.7% to 6.4% is considered
prediabetic, and a diabetes diagnosis can be made with an HbA1C over 6.5% (Eyth & Naik,
2021). Blood glucose levels of greater than 125 mg/dL are consistent with diabetes and correlate
to a HbA1C of approximately 6% (Eyth & Naik, 2021). Hemoglobin A1C goals are dependent
on age, health status or pregnancy (McCormick et al., 2019). In general, HbA1C goals are less
than 6.5% in a non-diabetic, 7% for a healthy and non-pregnant individual with diabetes, less
than 7.5% in healthy older adults, less than 8% in older adults with moderately complicated
health status, and less than 8.5% in adults with poor or complex health (McCormick et al., 2019).
Type 1 diabetes mellitus (T1DM) accounts for five to ten percent of diabetes etiologies
(American Diabetes Association, 2010). Type 1 diabetes results from defects of pancreatic beta
cells, which can be marked by islet of Langerhans autoantibodies, autoantibodies to insulin,
autoantibodies to GAD65, tyrosine phosphatases IA-2 and IA-2 beta (American Diabetes
Association, 2010). Therefore, there is destruction of insulin-secreting beta cells or an
inflammatory infiltrate that results in beta cells’ inability to regenerate (Atkinson et al., 2013).
Abnormalities or degradation of pancreatic beta cells result in the inability of the pancreas to
regulate blood glucose levels, causing hyperglycemia (Atkinson et al., 2013). The specific
etiology is still widely debated; however, research suggests there is a genetic and environmental
component in the development of T1DM (Atkinson et al., 2013).
While there are several different types of diabetes, the most prevalent is type 2 diabetes
mellitus (T2DM), which accounts for 90% of all diabetes diagnoses (American Diabetes
Association, 2010). Type 2 diabetes mellitus occurs as a result of insulin resistance (Kahn et al.,
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2013). Insulin resistance is characterized by the inability of beta cells to maintain normal blood
glucose levels due to increased insulin secretion, which results in increasing levels of blood
glucose (Kahn et al., 2013). Moreover, insulin resistance can lead to beta cells’ inability to
secrete insulin as the disease progresses (Kahn et al., 2013). Beta cell function has hereditary
components; therefore, genetics serve as a risk factor for developing T2DM due to the
correlation between numerous gene loci and obesity, insulin resistance, and beta cell function
(Kahn et al., 2013). Furthermore, caloric intake, decreased energy expenditure, nutrient
composition, and aging are important in the development of obesity, insulin resistance, beta cell
dysfunction, and glucose intolerance (Kahn et al., 2013). Dysregulation in the release of
glucagon also results in an increase in blood glucose concentration, though it is not well
understood if dysregulation is due to primary changes in alpha cells or occurs secondary to beta
cell dysfunction (Kahn et al., 2013).
Hormones found in the gastrointestinal tract, known as incretin hormones, work in
conjunction with islet cells and further aid in the regulation of glucose (Kahn et al., 2013). The
glucagon-like peptide 1 (GLP-1) works on beta cells to enhance insulin secretion and on alpha
cells to suppress glucose production (Kahn et al., 2013). Bile acids aid in regulation of glucose
metabolism as they activate the release of fibroblast growth factor (FGF19), which has
insulin-like effects, such as the induction of glycogen synthesis and the inhibition of glucose
production (Kahn et al., 2013). Bile acids produce proteins that lead to the cascade of GLP-1
production (Kahn et al., 2013). The vagus nerve regulates islet cells and the hypothalamus
regulates circadian rhythms, beta cell regulation, and other metabolic processes (Kahn et al.,
2013). The brain further regulates hepatic production of glucose through direct neuronal input,
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and feedback loops of insulin and glucose (Kahn et al., 2013). Lastly, systemic inflammation has
correlated with beta cell dysfunction and insulin sensitivity (Kahn et al., 2013).
Treatment Methods
Treatment of T1DM aims for blood glucose regulation to prevent the possibility for
associated complications, such as retinopathy, neuropathy, cardiovascular disease, hypoglycemia,
and more (Atkinson et al., 2013). For T1DM management, the pancreas does not produce
insulin, thus injectable hormonal insulin is necessary to regulate blood glucose levels (Atkinson
et al., 2013). Insulin can be taken either by manual injection or continuous infusion from an
insulin pump (Atkinson et al., 2013). Manual injections may be given utilizing different types of
insulin, including a long-acting basal dose and a short-acting dose that is dosed as needed,
several times per day, for grams of carbohydrates consumed (Atkinson et al., 2013). Blood
glucose levels are monitored by manual blood testing or a continuous glucose monitor and are
regulated by insulin dose adjustments (Atkinson et al., 2013). Currently, continuous glucose
monitors and insulin pumps work in conjunction as a closed-loop system and are referred to as
an artificial pancreas (Asarini et al., 2021). The closed-loop system has shown improvements in
HbA1C, reduced events of hypoglycemia, and improvements in quality of life (Asarini et al.,
2021). Despite new advances in technology, there is no prevention, cure, or reversal for T1DM.
Similar to T1DM, treatment of T2DM emphasizes the reduction and maintenance of
blood glucose levels (Kahn et al., 2013). Drugs that mediate through the gastrointestinal tract
include alpha-glucosidase inhibitors, which decrease the speed of glucose absorption by delaying
the breakdown of carbohydrates (Kahn et al., 2013). Pramlintide slows gastric emptying, which
in turn delays glucose absorption (Kahn et al., 2013). Colesevelam binds to bile acid to lower
cholesterol and regulate release of various gastrointestinal peptides to reduce plasma
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concentrations of glucose (Kahn et al., 2013). Incretin-related products are also available;
however, their mechanism is not well understood and has a variety of associated risks (Kahn et
al., 2013). Sodium-glucose co-transporter 2 (SGLT2) reabsorbs glucose from the urine; therefore,
SGLT2 inhibitors inhibit reabsorption of glucose and gluconeogenesis from the kidneys (Kahn et
al., 2013). Currently bromocriptine, a dopamine-receptor agonist, is the only drug approved to
work through the central nervous system to regulate glucose metabolism and does so by targeting
the restoration of circadian rhythm (Kahn et al., 2013). Additionally, a variety of insulin
therapies are available that differ in mechanism of action, onset of action, and concentration.
Regardless, each has shown effectiveness at improving blood glucose regulation in those with
T2DM (Kahn et al., 2013).
While there are a variety of pharmaceutical agents utilized to treat diabetes, lifestyle
modifications have been utilized and serve as a preventative measure or as subsequent adjunct to
medication therapy. Decreased insulin sensitivity, or insulin resistance, refers to an impaired
response to insulin, resulting in blood glucose elevation (Wilcox, 2005). Insulin mediates blood
glucose reabsorption into adipose and skeletal muscle through GLUT 4 transporters (Wilcox,
2005). When there are defects in insulin action or impaired GLUT 4 translocations, there are
impairments in glucose transportation, resulting in increased blood glucose (Wilcox, 2005).
Lifestyle modifications such as exercise and diet have been taught to patients with
diabetes due to their ability to improve insulin sensitivity by stimulating skeletal muscle and
reduction in adipose tissue, thereby decreasing insulin resistance (Wilcox, 2005). Since T2DM is
often a result of insulin resistance, individuals may be able to reduce pharmaceutical
interventions or reverse their diagnosis utilizing lifestyle modifications. Lifestyle modifications
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serve as a beneficial therapy for reducing complications and increasing insulin sensitivity
(Wilcox, 2005).
Current Patient Education
The American Diabetes Association (ADA) recommends that individuals with diabetes
be referred to a diabetic education program upon diagnosis, annually after diagnosis, when
management becomes difficult, and when significant changes occur such as a change in health
insurance (American Diabetes Association, 2021). The Centers for Disease Control and
Prevention (CDC) states the objectives of these education programs, which aim to improve
understanding of diabetes and its treatment, promote healthy eating, physical activity, medication
compliance, blood sugar level awareness, risk reduction for other healthcare problems, and
coping with psychological issues such as stress and depression (“Managing Disease,” 2018).
Despite these diabetic education programs, only 14.3% of patients with diabetes are able to
maintain their HbA1C levels at the appropriate target of less than 7 percent (Chrvala et al.,
2015).
The current education regimen comes directly from the American Diabetes Association
and the American Association of Diabetes Educators. Diabetes self-management education and
support (DSMES) courses typically consider an individual's health literacy, competency, prior
education level and knowledge of the disease, familial support, healthcare beliefs, and more
(Powers et al., 2015). The goal of education is to increase patient understanding of the disease in
order to properly manage it. The ADA recognizes that education about the disease is beneficial
in reducing HbA1C levels, prompting the increased development of DSMES services (Chrvala et
al., 2015). Services include psychosocial components, nutrition, exercise, risk reduction and
complications, and monitoring blood glucose and medication management (Powers et al., 2015).
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The utilization of these services decreases patients’ HbA1C level by as much as one percent on
average (Powers et al., 2015). The objective of these services is to educate patients on their
diabetes diagnosis in hopes that they understand the disease well enough to manage it on their
own and in conjunction with their provider (Powers et al., 2015).
Educational resources are available in different formats throughout the United States.
Educational services used to be in a formal setting but are now available outpatient, inpatient, in
pharmacies, home care facilities, and in an online format (Powers et al., 2015). The first step
after diagnosis is to receive what is known as survival-level education, which is the bare
minimum of information a newly diagnosed diabetic patient needs to know to manage their
diagnosis before diabetes self-management education occurs (Powers et al., 2015). After the
initial diagnosis, patients and their families should remain in close contact with someone in their
care team to get any questions answered and to tailor DSMES specifically to their needs (Powers
et al., 2015). Unfortunately, a large number of patients with diabetes do not utilize these services
to the fullest extent, largely stemming from providers underutilizing referrals (Powers et al.,
2015).
According to a systematic review performed by Steinsbekk et al. (2012), group based
DSMES has demonstrated effectiveness in lowering HbA1C in patients with type 2 diabetes by
0.87% over 2 consecutive years. The review included 21 total studies that evaluated group based
DSMES compared to routine treatment (Steinsbekk et al., 2012). These studies were randomized
control trials and concluded that group based DSMES improves T2DM through clinical,
lifestyle, and psychosocial methods (Steinsbekk et al., 2012). Factors that were studied and
benefited from group based DSMES include HbA1C, fasting blood glucose, diabetes knowledge,
self-management skills, empowerment, and self-efficacy (Steinsbekk et al., 2012). Fasting blood
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glucose decreased in the intervention groups by 1.26 mmol/l in five studies over 12 months
(Steinsbekk et al., 2012). The intervention groups reported higher levels of patient satisfaction
and weight management as well (Steinsbekk et al., 2012).
One way that education is able to help diabetic patients is by teaching them how to
control their HbA1C (De la Fuente Coria et al., 2020). Face-to-face education sessions with
follow up reinforcement sessions using material proposed by the American Association of
Diabetes Educators (AADE) have been shown to decrease a patient's glycated hemoglobin (De la
Fuente Coria et al., 2020). Education sessions also have a positive effect on fasting blood
glucose, total cholesterol, low-density lipoprotein, and systolic blood pressure (De la Fuente
Coria et al., 2020). A systematic review that was conducted under AADE protocols reviewed 118
interventions that found significant changes in HbA1C (Chrvala et al., 2015). The intervention
group had an average reduction of 0.74 in HbA1C, and the control group had a mean reduction
of 0.17 (Chrvala et al., 2015). Higher success was found in groups with greater than 10 hours of
contact time as well as group and individual interactions (Chrvala et al., 2015).
Not only do DSMES services help patients with diabetes and their family members
remain accountable for their health, but they also assist in decreasing the burden of the
diabetes-associated costs on the United States healthcare system (Powers et al., 2015). In 2012,
the United States healthcare system spent $245 billion on diabetes care and is estimated to rise
based on the prediction that one in three persons will be diagnosed with T2DM by 2050 (Powers
et al., 2015). Despite the importance of these services as deemed by the ADA, only seven percent
of newly diagnosed patients with diabetes with private insurance and five percent of those with
Medicare will use DSMES services in their first year of being diagnosed (Chrvala et al., 2015).
This is a drastically small number that once increased, could improve patient outcomes, number
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of hospitalizations, rehospitalizations, and complications related to the disease (Powers et al.,
2015). Patients with diabetes and their providers should fully utilize DSMES services to limit
further increases in cost to the healthcare system.
Patients with diabetes have a variety of educational resources available to them in all
areas of the United States. Services provided by DSMES are the primary resources utilized,
recommended by the ADA, and studied in literature. However, these services only briefly
describe the importance of medication compliance and lifestyle modifications, and how those
factors improve diabetes management. Despite the educational resources available to patients
with diabetes, there is a gap in literature and educational materials in which patients are able to
learn and comprehend the physiology behind their condition, and why such treatment methods
improve disease outcomes.
Health Literacy
Up to half of the adults in the U.S. do not understand the information they receive from
their health system (“Minnesota Health,” n.d.). Individuals with inadequate health literacy are
less likely to seek preventative care, follow treatment plans, and ask questions (“Minnesota
Health,” n.d.). Therefore, overcoming health literacy requires communication that is empowering
between both the provider and patient (“Minnesota Health,” n.d.).
Patients with lower education, immigrants, older individuals, and racial and ethnic
minorities are more likely to have poor health literacy (Schillinger et al., 2002). There is a
correlation between chronic medical conditions, such as T2DM, and having a lower level of
health literacy (Schillinger et al., 2002). In conjunction, ethnic minorities and individuals of
lower socioeconomic status have a much higher rate of T2DM among those populations
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(Schillinger et al., 2002). Patients with lower health literacy were found to have two times the
rate of diabetic complications (Schillinger et al., 2002).
Comprehension of oral communication may also be limited in patients with lower health
literacy (Schillinger et al., 2002). Spoken language for those with lower literacy levels has been
associated with worse glycemic control measured by HbA1C values (Rothman et al., 2005; Al
Sayah et al., 2015). Provider communication may lack the available time and skills to
appropriately educate patients in the most effective manner (Schillinger et al., 2002). Brunk et al.
(2017) found diagram-like tools to be beneficial for Spanish-speaking patients with T2DM.
Lifestyle modifications and blood sugar monitoring were among the topics presented (Brunk et
al., 2017).
The effectiveness of interventions can further be improved if patients are also provided
written information regarding diabetes, treatment methods, or the importance of lifestyle
modifications (Caetano et al., 2018). Caetano et al. (2018) noted that the most noticeable benefit
of providing written information was an improvement of medication adherence. The
effectiveness of written material is correlated with a patient’s education level; therefore,
individuals who are less educated benefit the most (Caetano et al., 2018). It was concluded that
health literacy and compliance improved with the use of written materials, which further
demonstrated the need for written educational materials as part of the project’s goal to provide
physiological understanding of diabetes to patients.
Patient Understanding Related to Disease Physiology
The physiological marker, HbA1C, reflects the average blood glucose control over a
three-month period and is utilized to diagnose diabetes and assess disease management (Trivedi
et al., 2017). While the HbA1C is most commonly used to monitor disease control, the amount of
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medication and use of insulin is another form of disease assessment that is utilized (Gopalan et
al., 2018). In general, a higher HbA1C value or increased dosage of insulin is indicative of a
decrease in blood glucose control and is associated with increased risk of disease complications.
Other factors that may contribute to disease management include health literacy and
self-motivation (Gopalan et al., 2018).
Patients’ knowledge and understanding of HbA1C has been correlated to improvement of
disease outcomes (Trivedi et al., 2017). Despite the increase in educational tools by the ADA
within the last decade, the utility of this physiological marker is poorly understood by patients
(Trivedi et al., 2017). On average, only 25% of patients with diabetes have an accurate
understanding of HbA1C and maintain the competency to report on their HbA1C levels (Beard et
al., 2009). Patient understanding of what HbA1C represents is correlated to better blood glucose
control (Beard et al., 2009). Aside from HbA1C lab values, patients rely on self-monitorization
of blood glucose, diabetes-related symptoms, and amount of medication taken to assess their
overall disease control and severity (Gopalan et al., 2018). The range of symptoms associated
with elevated blood glucose levels vary, causing patients to falsely attribute acute symptoms of
general malaise and fatigue as disease complications, despite their broad nature (Gopalan et al.,
2018). Additionally, self-monitoring blood glucose tests have limited effectiveness as they only
provide one value at a given point in time (Gopalan et al., 2018).
The understanding of the disease often comes from provider-patient interactions, online
searches, and education courses. Patient education on lifestyle modifications and management of
T2DM is readily available; however, only one in five newly diagnosed patients with diabetes
attend these education classes (Ledford et al., 2020). One study found that 24% of patients
wanted more information after receiving their diagnosis (Ledford et al., 2020). The quality and
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reliability of information patients receive is essential in a proper understanding of their diagnosis.
In one patient’s experience of meeting with a specialist, she described how her provider
explained the disease processes more in depth regarding the organs’ functions and how they are
affected, rather than a basic description of blood glucose levels (Ledford et al., 2020). The
provider also gave thorough descriptions on how the medications work in the body and the
patient stated that the information improved the understanding and management of her diagnosis
(Ledford et al., 2020). Patients who were solely informed on their laboratory values, specifically
their HbA1C, did not understand the reasoning behind the need for improved blood glucose
management and were simply informed to take specific medicine (Ledford et al., 2020). These
patients noted they felt there was information missing in order to properly manage their diabetes
(Ledford et al., 2020). Patients who receive more information, guidance, and instructions from
medical providers tend to be more involved in their treatment plan, which has been linked to
higher compliance (Quinn et al., 2011). When patients sought for further information online,
some individuals reported more confusion (Ledford et al., 2020).
Patient-friendly information that explains the physiology of T2DM is not readily
available, making it a necessity for the medical and educator communities to develop such
information. There is a gap in educational materials and research for physiology-specific patient
education. Searches were conducted with the following databases: PubMed, CINAHL,
DynaMed, NCBI, and Google Scholar. These searches yielded no applicable results to the
problem statement of this study. This further highlighted the importance to create and implement
physiology-specific education materials for patients with type 2 diabetes.
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Conclusion
Disease pathophysiology and physiology regarding the treatment methods of T2DM are
complex, but well understood by healthcare providers and DCES. Current educational tools
emphasize the importance of lifestyle modifications and medication compliance for
improvements of disease management. Nevertheless, their mechanisms are not well understood
by or conveyed to patients. Additional education emphasizing the physiological reasoning behind
such recommendations should be created and readily available for patients with diabetes.
Chapter three discusses the methodology regarding implementation of these educational
resources.
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Chapter 3: Methodology
Introduction
Neighborhood HealthSource (NHS) had the need for physiology-related type 2 diabetes
mellitus (T2DM) education material. The pamphlet outlines key terminology utilized for T2DM,
cellular physiology of elevated blood glucose, and the organs involved with its pathophysiology.
The T2DM epidemic and inadequate patient understanding of its disease and treatment
physiology prompted the necessity for the development of this pamphlet. The current regimen of
education for T2DM patients is inadequate in providing patients with comprehensible reasoning
for the purpose of lifestyle and pharmaceutical changes, compelling the creation of this project.
By providing patients the physiology of their diabetes diagnosis at an understandable level, it
was anticipated that there would be an improvement in disease understanding. This chapter
discusses the methodology of the project, including the rationale behind the project, the
population it serves, its implementation, tools, and potential barriers to completion of the project.
Rationale for Project
Neighborhood HealthSource is a non-profit organization of primary care clinics that has
been established for over 50 years (Neighborhood HealthSource, 2022). The clinic is classified
as a Federally Qualified Health Center (FQHC), which is a community health center clinic
funded by the federal government to provide primary care in under-served areas. Neighborhood
HealthSource serves the population of northeast Minneapolis, specifically those patients that are
in need of affordable and accessible healthcare. “The mission of NHS is to improve the health of
communities by providing quality healthcare services that are affordable and accessible, while
advancing health equity for all” (Neighborhood HealthSource, 2022). Neighborhood
HealthSource strives to cultivate an inclusive, diverse, and respectful environment for all
cultures. The aim of NHS is to eliminate cost as a barrier for patients to receive care by accepting
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patients with and without insurance, as well as patients who struggle to pay for care. The federal
government funds NHS to provide healthcare access in under-served areas.
Neighborhood HealthSource has expressed a need for easily understandable and
accessible T2DM education information that patients can utilize during their in person or virtual
clinical visit (R. Kirchner, personal communication, January 12, 2022). This project aimed to
develop a physiology-based educational pamphlet for patients with type 2 diabetes that can be
utilized in their appointments at the clinic and referenced outside of the clinic. Currently, the
services provided by the DCES are free to the clinic's patients. The certified DCES, Ranelle
Kirchner, at NHS expressed a need for electronic and physical materials that provide a
patient-friendly explanation of diabetes, high blood glucose, and medical terminology related to
diabetes. Current education materials provided by the clinic are available in physical form and
not easily accessible in electronic distribution. Additionally, current educational materials do not
provide patient-friendly physiological explanations, leading to a gap in patient understanding.
With the implementation of the project and use of the pamphlet, the DCES at NHS has
readily available and accessible explanations of the T2DM disease process. The pamphlet assists
the DCES in their explanations of diabetes-related physiology. The goal of the project was that
by providing patients with written and visual explanations of their diabetes diagnoses, their
understanding of their disease will improve, thus leading to improved patient outcomes. This is
important to NHS and its population because it has the ability to improve patient understanding
in a diverse patient population. Specifically, presenting the physiology of T2DM in a
patient-friendly manner improves patient comprehension of their disease, thus possibly
improving their disease management.
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Population
Neighborhood HealthSource was in need of the pamphlet this project was designed to
create. The pamphlet aids as visual material for patients and guides their comprehension of
T2DM using easily understood wording and imagery. Neighborhood HealthSource and Kirchner
agreed (Appendix A) to work alongside the project and distribute the material to the entirety of
the diabetic patient population at NHS. In 2020, Kirchner completed 617 diabetic education
appointments, both in-person and virtually (Neighborhood HealthSource, 2022). These
appointments largely targeted hispanic, black, and white patients in the Minneapolis, Minnesota
area. The pamphlet assists Kirchner in these routine diabetic education visits with patients both
in the office and in the telehealth setting. It is also available in print and for electronic
distribution for patients to answer any questions that may not have been addressed during their
visit.
Project Plan and Implementation
The pamphlet is available for print and electronic distribution and was created to fulfill
the needs of NHS. The design is based on the generalized verbal information that the educator
currently utilizes to explain the disease process during individualized appointments. Patients now
have a tangible resource to visually connect the verbalized information. This has been given to
patients to take home and sent electronically so they can reference it again. The pamphlet is
available with the NHS Canva account and with their DCES’s education materials at the clinic.
This project did not include interactions with patients to obtain information or data;
therefore, there were no ethical implications. There were no difficulties in the implementation of
this material.
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Project Tools
The pamphlet was created using the design website, Canva.com (Canva, 2021). Canva
allows the user to pick from thousands of templates to start. This pamphlet was designed using a
stock template and was manipulated to make it unique to the project. Canva also includes many
images for free use, with the option of premium images and content for an added charge (Canva,
2021). The website allowed for the project to be shared and edited by multiple people within a
Canva team for the pamphlet’s creation. Information collected from the needs assessment of
NHS clinics was utilized to create a comprehensive tool used to teach patients with diabetes
about their T2DM diagnosis.
The major sections of the pamphlet include definitions of common diabetes terminology,
cellular level pathophysiology of T2DM, and systemic pathophysiology of uncontrolled T2DM
on other organs. Trifold sectioning was used as the layout for the pamphlet. The first section
includes a title page for the pamphlet. The three inside folds of the pamphlet feature the cellular
mechanism of blood glucose intake and the implications high blood glucose has on those with
T2DM that may lead to complications. Finally, the definition of common terminology used in
T2DM discussion is placed on the back two sections of the pamphlet along with an area to
provide the patient with their individualized HbA1C goal. This layout provides easy navigation
of the resource. The definition of terms include commonly used terms in Kirchner’s T2DM
education appointments that need to be included for NHS’s specific patient population. Cellular
physiology of T2DM targets the patients’ comprehension of the mechanism by which blood
glucose is transported into and out of the cell in a normal state, as well as in a diabetic state of
insulin resistance. Canva assisted in the creation of these images and elements needed to recreate
the process of insulin’s role in cellular uptake of blood glucose. The intention behind teaching
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patients how blood glucose works within the body was to relate the intensity of blood glucose
levels to the possible complications that may result from uncontrolled T2DM. In conjunction
with Kirchner and the Chapter 2: Literature Review, the pamphlet discusses possible outcomes of
T2DM when blood glucose is uncontrolled, as deemed by long term elevation of HbA1C. The
complications briefly discussed in Chapter 2 were the basis for which complications were to be
included in the pamphlet. These included kidney disease, heart disease, neuropathy, and diabetic
retinopathy.
Potential Barriers
The implementation of this project was developed to help alleviate potential
communication and accessibility barriers. Neighborhood HealthSource serves a large
Spanish-speaking population; there could be a lack of effectiveness if patients cannot read the
information presented in English. To account for patients who may have a lower health literacy,
there are written definitions, brief descriptions, and graphics to present the information in more
than one way. With the NHS logo present on the pamphlet, the material can only be utilized as
part of the clinics’ education curriculum. Therefore, the logo was omitted to allow outside
educators and networks to utilize the resource. The increasing number of telehealth visits limits
the ability to share the pamphlet in person. Having an easily accessible electronic version that
can be shared with patients via email will help to eliminate that barrier. Foreseeable barriers of
the project have been identified and accounted for to create valuable information and a
successful implementation.
Conclusion
The implementation of the pamphlet fulfilled the need of the DCES from the NHS clinics
by providing an easily accessible and understandable T2DM education resource. By providing
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patients a visual of the cellular physiology of elevated blood glucose, organs involved in diabetes
pathophysiology, and commonly utilized diabetes related vocabulary, an improvement in patient
understanding was anticipated. Chapter four serves as a discussion on how the project was
implemented, as well as NHS’s reception of the new material.
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Chapter 4: Discussion
Introduction
The increasing prevalence of type 2 diabetes mellitus (T2DM) and diabetes
complications underscores a need for additional patient education to improve health literacy and
health outcomes. Current literature emphasizes blood glucose control by medication and lifestyle
modifications to reduce diabetes-related complications; however, the physiological reasoning
behind those implementations is not often conveyed to the patient. This results in a lack of
patient understanding about their disease, which further leads to poor health outcomes.
Neighborhood HealthSource (NHS) has expressed the need for physiology-based education for
their patients with T2DM (Neighborhood HealthSource, 2022). An electronic pamphlet to fulfill
this need was created and incorporates patient-friendly information on the disease
pathophysiology, complication pathophysiology, risk factors, and diabetes-related terminology.
This chapter will provide a summary of the pamphlet’s results, limitations, considerations for
further projects, and conclusion of the project.
Summary of Results
Patients with diabetes are given information on how to decrease their blood glucose using
diet, exercise, and medications, yet these patients are not given information on the
pathophysiology of T2DM. Furthermore, it is not always clear to patients how these
interventions impact T2DM physiologically. If patients understand the disease state and how the
treatment plan impacts their disease process, there will be better opportunities for disease
control, thus decreasing the complications associated with T2DM. Patients understand concepts
better when they are provided with written materials (Caetano et al., 2018). This is especially
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important for patients with lower education levels as written materials provide a greater benefit
than verbally communicated information (Caetano et al., 2018).
A written pamphlet was created to address the gap in knowledge of T2DM
pathophysiology amongst newly diagnosed patients with T2DM. The reading level of the
pamphlet is presented at an eighth grade level to allow use for a variety of patients. Through
coordination with Ranelle Kirchner, the Diabetes Care and Education Specialist (DCES) at NHS,
several drafts were proposed of the pamphlet using Canva.com. Emails and video calls were
utilized for electronic correspondence in determining changes to each pamphlet draft. Kirchner
confirmed her approval (Appendix B) of the final copy and this was sent to the NHS Canva
account for easy distribution both electronically and in print. Tools for the resource development
process were not limited. This allowed for effective implementation into the clinical practice by
the Kirchner’s DCES practice at NHS. The timely manner of this project allowed patients to
benefit from this resource sooner than anticipated. Patients at NHS have benefited by gaining a
more solidified understanding of their T2DM disease process. The overall creation and
implementation of this project went as expected, without significant limitations.
Limitations
A limitation that was encountered during this project was not having the expertise to
create a Spanish version of the pamphlet. Due to the high prevalence of native Spanish speaking
individuals in the NHS population, having a Spanish version of this pamphlet would have further
aided in NHS’s need. Furthermore, since the pamphlet was created at an eighth grade reading
level there may be a barrier for those whose health literacy falls below an eighth grade reading
level.
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Further Projects
The pamphlet created provided basic information on the physiology of T2DM which can
be used in printed or electronic form. However, in consideration for the needs of the pamphlet
requiring or benefiting from changes, the final product for this project was shared with NHS as a
template through Canva.com. This allows NHS to make translations, add information, change
wording, or make further changes if needed in the future.
The Minneapolis, Minnesota area that NHS serves is diverse with individuals speaking
languages other than English. Being translated into another language is an opportunity for further
serving other communities. Presenting the physiological information for varying levels of health
literacy is another way to further this project. An example of this would be to create versions
above and below an eighth grade reading level. Another option to further this project for those
with higher education would be to provide more detail of the physiologic processes of T2DM.
There is potential for this project to seek further modifications based on the needs of NHS or
changes in recommendations for T2DM by the American Diabetes Association.
Conclusion
Diabetes mellitus (DM) is a group of diseases that is categorized by the body’s inability
to regulate blood glucose due to a variety of metabolic abnormalities (American Diabetes
Association, 2010). Type 2 diabetes is a multisystemic disease that accounts for over 90% of the
diabetes diagnoses, affects more than 370 million people worldwide, and costs the U.S.
Healthcare System over $245 billion per year (Kahn et al., 2013; Powers et al., 2015). With the
implications of T2DM on the individual, provider, and society, it is evident there is a need for
better health outcomes in patients with diabetes. Current education serves to improve health
outcomes for patients with diabetes through medication compliance and lifestyle modifications.
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Diabetes education has been shown to decrease a patient’s hemoglobin A1C and
positively improve fasting blood glucose, total cholesterol, low-density lipoprotein, and systolic
blood pressure, with more benefit being seen in patients who have face-to-face interactions (De
la Fuente Coria et al., 2020). The effectiveness of interventions can further be improved if
patients are provided written information; however, written information must be presented at the
individual’s health literacy levels (Caetano et al., 2018). The current education regimen does not
adequately convey the physiological reasoning behind those recommendations, which results in a
lack of patient understanding behind those implementations. This project serves to alleviate that
gap by providing new resources that emphasize patient understanding of the pathophysiology
behind diabetes diagnoses.
Neighborhood HealthSource has expressed a need for easily understandable and
accessible pathophysiology-based T2DM education information that patients can utilize during
their clinic visits (R. Kirchner, personal communication, January 12, 2022). Neighborhood
HealthSource is a federally qualified health center that provides primary care to underserved
patient populations (Neighborhood HealthSource, 2022). Barriers considered when creating the
pamphlet were the clinics’ large Spanish speaking population, lower health literacy levels, ability
to be electronically distributable, and omission of the NHS logo to allow other clinics and the
DCES to utilize the resource. It is the goal of this project to have developed a physiology-based
educational pamphlet for NHS that can be utilized to educate patients with T2DM. Indirectly,
this project hopes for patients with T2DM to use their improved understanding to further aid in
their disease management and reduce diabetes-related complications.
This project has further aided in the education and professional development of the
researchers. The implications of diabetes on the individual and community demonstrate the need
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for earlier intervention and proper education to limit disease outcomes. The literature findings
reiterated the effectiveness of patient education as seen with the reduction of HbA1C and
complications when DSMES is utilized (Chrvala et al., 2015). The importance of health literacy
when providing education was further emphasized throughout this project. With up to half of
U.S. adults not understanding the information they receive from their health system, and
individuals with lower health literacy being less likely to seek preventative care, comply with
that care, or ask questions, it is evident health literacy should be considered during patient visits
(“Minnesota Health,” n.d.). Presenting information to patients through an individualized
approach just as a provider would individualize treatment methods or HbA1C goals, will further
improve diabetes management and patient’s understanding of their T2DM.
Limitations regarding variations in language proficiency, health literacy, and management
goals were identified upon completion of the pamphlet. Future projects should continue to
emphasize patient-physiological understanding though an expansion for more options in different
languages and different health literacy levels should be created. The pamphlet utilizes a
combination of definitions and visuals that are written at an eighth grade reading level to account
for the lower health literacy in NHS’ population. Due to time constraints a Spanish version of the
pamphlet was unable to be created. Neighborhood HealthSource received access to edit the
pamphlet in order to create a Spanish version as well as continue editing or utilizing the
pamphlet as a template as needed. Neighborhood HealthSource found the pamphlet to be
beneficial in its clinic and telehealth appointments. Kirchner expressed that there appeared to be
a better overall initial patient understanding when initially presented with the information
(Appendix B). Overall, the project’s basis, design and implementation was successful.
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